Skip to main content
MOS logo

MOS · Mosaic Co

Track MOS — free
$18.85 -1.00 (-5.02%)
Market Cap
$6.08B
Shares
317.90M
Volume · Nov 20 7.64M Avg daily vol (3M) 9.42M

Price & Indicators

 

Key stats

Close
$19.85
Thu 19 Nov
Open
$19.79
Thu 19 Nov
Average volume, 30 days
10.4M
shares a session
Short interest
37.3M
11.7% of shares · 3.4 days to cover
Day range
$19.21$19.92
Open $19.79 Close $19.85
52-week closing range
$17.27$31.36
Close $19.85 36.7% under the high
Short volume, last session
44%
Last earnings
Nov 4, 2026
Latest filing
10-Q · Nov 4
Price history
Jan 2020 to Nov 2026

Up next

Feb 24, 2027 Est · unconfirmed · in 14 wks

Latest documents

2026
Nov 4
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Sulfur constraints drive quarterly loss and production curtailments

Mosaic reported a $72.1 million net loss for the three months ended September 30, 2026 and a $602.5 million loss for the nine months ended September 30, 2026, as sulfur constraints and higher input costs pressured margins and phosphate production was curtailed.

Revenue $3.1B ▼ 10.2% Net loss $72.1M Diluted EPS -$0.23
Read from the MD&A section
3 source passages
For the three months ended September 30, 2026, Mosaic incurred a net loss of $72.1 million, or $(0.23) per diluted share, compared to net income of $411.4 million, or $1.29 per diluted share, for the same period last year. For the nine months ended September 30, 2026, Mosaic incurred a net loss of $602.5 million, or $(1.90) per diluted share, compared to net income of $1,060.2 million, or $3.33 per diluted share, for the same period a year ago. In response to current market conditions and limited sulfur supply, we decided to temporarily curtail production at additional phosphate production facilities in North America, as well as extend curtailed phosphate production in North America and Brazil. Open the document at this passage
Nov 4
Earnings call
Cost cuts and sulfur savings support cash flow

Mosaic expects positive free cash flow in the second half of this year, targets 2027 SG&A below $500 million and CapEx below $1 billion, and secured fourth-quarter sulfur supply at $615 per ton while curtailing phosphate production.

5 source passages
For the fourth quarter, we've secured supply at $615 per ton. We expect 2026 SG&A to be $510 million to $530 million, but our cost reduction initiatives suggest 2027 SG&A to be below $500 million. Based on our current plans, we are targeting below $1 billion of capital expenditures in 2027, roughly $200 million below where we expect to finish 2026. Even with production curtailments in the U.S. and Brazil, we expect to generate positive free cash flow in the second half of this year. As affordability improves and growers replenish nutrients following an extended period of underapplication, we are confident that Mosaic is positioned to generate stronger cash flow and returns as market conditions normalize. Open the document at this passage
Nov 3
Current report 8-K
Third-quarter net loss of $72 million

Mosaic reported a net loss of $72 million and adjusted EBITDA of $324 million for the third quarter of 2026, versus net income of $411 million in the same quarter of 2025. Full-year potash production is expected to be 8.6 million tonnes.

Financial results Read from the first part of this long document
3 source passages
TAMPA, FL, November 3, 2026 - The Mosaic Company (NYSE: MOS), reported a net loss of $72 million and diluted loss per share of $0.23 for the third quarter of 2026. Adjusted EBITDA(1) was $324 million and adjusted loss per share(1) was $0.19. Mosaic reported a third quarter net loss of $72 million, compared to net income of $411 million in the same quarter of 2025. As a result, full-year potash production is now expected to be 8.6 million tonnes in 2026. Open the document at this passage
Sep 25
Current report 8-K Events of Sep 23
Director or officer change, or executive pay

Mosaic appointed Walter F. Precourt, III Executive Vice President - Operations effective December 1, 2026. Karen A. Swager will resign from the same role that day, serve as Senior Advisor, and retire in the second quarter of 2027.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$11.90B
Trailing 12 months
Net income (TTM)
−$1.12B
Trailing 12 months
Revenue growth YoY
-10.2%
Year over year
Operating margin
-5.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-13.3%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$5.13B
Latest balance sheet
Dividend yield
4.4%
Trailing 12 months
Shares change YoY
-0.5%
Year over year · fewer shares
Price change (1Y)
-19.0%
Trailing year
Short interest
11.7%
Latest settlement · 3.4 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 5, 2026
Q2 FY26

TL;DR. Mosaic swung to a Q2 net loss of $273 million on sulfur-driven phosphate curtailments, but secured Q3 sulfur at $705/long ton well below spot, cut 2026 capex to $1.2 billion, and maintained $407 million of adjusted EBITDA while potash held flat year-over-year at $278 million.

Bullish
  • + Locked in Q3 sulfur at $705/long ton, considerably below current spot market.
  • + Reduced 2026 capital expenditures outlook to $1.2 billion from $1.25 billion.
  • + Potash segment delivered $278 million of adjusted EBITDA, equal to the prior-year quarter.
  • + Mosaic Biosciences expected to double 2026 revenues versus 2025's $68 million.
  • + Fortified liquidity with a $1 billion term loan to refinance short-term commercial paper and left $2.5 billion revolver untapped.
Bearish
  • − Phosphate and Fertilizantes segments swung to operating losses as production was curtailed.
  • − Mosaic Fertilizantes Q3 adjusted EBITDA expected to fall below the $60 million Q2 result amid full-quarter impact of curtailments.
  • − Q2 free cash flow was negative $153 million as operating cash flow fell to $167 million from $610 million.
  • − Q2 results included $351 million of pre-tax notable items, including a $162 million Ma'aden mark-to-market loss and $69 million project write-off.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 28.4 · fear Equity put/call 0.62
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −15%
below
Price vs 50-day avg −6%
below
RSI (14) 44
neutral
MACD trend Negative
52-week position 18%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +15%
trailing
6-month return −15%
trailing
YTD return −18%
this year
Relative strength −9%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $21 › 200d $23 — 200d above 50d
Institutional flow Accumulating
+2% holders QoQ · +107 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
11.75% of shares out · ▲ +10.5% MoM · 3.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
695 holders — mid 3-yr range
Squeeze score 73
high risk · 0–100
Fundamentals
Strong
Revenue growth +8%
Y/Y
Gross margin 16%
expanding
EPS growth +209%
Y/Y
Free cash flow $-534.6M
Buyback $3.0B
authorized
Balance sheet $4.8B
net debt
Quant / Vol
risk profile
Very High
Volatility 48%
annualized · 1-yr
Max drawdown −45%
past year
ATR 4.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 4, 2026
fourth quarter
Realized sulfur prices and cost of goods sold $800 – $850
Ammonia costs $590 – $610
2026
SG&A $510M – $530M
Mosaic Biosciences net sales Maintained $135M
Nov 3, 2026 $135M changed to Nov 4, 2026 $135M
2027
SG&A up to $500M
Capital expenditures up to $1B
Previous outlook earlier release · from the 8-K filed Nov 3, 2026

Still-open targets the latest release did not restate under the same label.

Total Capital Expenditures · 2026 $1.2B
Capital expenditures · 2027 up to $1B
DAP prices at the plant · Fourth Quarter 2026 $820 – $840
Realized mine gate MOP prices · Fourth Quarter 2026 $255 – $275
DAP FOB Plant Prices - $ per tonne · Fourth Quarter 2026 $820 – $840
Prior guidance period ended · from the Earnings Call filed Aug 5, 2026
Realized sulfur costs · for the third quarter $700 – $710
Ammonia costs · for the third quarter $610 – $620
DAP FOB pricing guidance · third quarter $820 – $840

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−15% Bearish
Price vs 50-day avg
−6% Bearish
RSI (14)
44 Neutral
MACD trend
Negative Bearish
52-week position
18% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $21 › 200d $23 — 200d above 50d
Institutional flow Accumulating
+2% holders QoQ · +107 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
11.75% of shares out · ▲ +10.5% MoM · 3.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
695 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $17 Now $20 · 18% Range high $31
vs 200-day avg -15% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Average finished product selling price (Mosaic Fertilizantes) $585 Three months ended June 30, 2026 filing —
Average finished product selling price (Potash) $280 Three months ended June 30, 2026 filing —
Brazil MAP price (delivered price to third party) $835 Three months ended June 30, 2026 filing —
Brazilian phosphate rock production 0.7M the three months ended June 30, 2026 filing —
Mosaic Fertilizantes average cost - Ammonia $815 Three months ended June 30, 2026 filing —
Mosaic Fertilizantes average cost - Blended rock $105 Three months ended June 30, 2026 filing —
Mosaic Fertilizantes average cost - Sulfur $516 Three months ended June 30, 2026 filing —
Operating rate for potash production 64% Three months ended June 30, 2026 filing —
Operating rate for processed phosphate production 58% Three months ended June 30, 2026 filing —
Phosphate operating rate 47% the three months ended June 30, 2026 filing —
Adjusted EBITDA non-GAAP 407M Q2 2026 —
Adjusted EBITDA (Phosphate segment) non-GAAP $128M Q2 2026 —
Adjusted EBITDA - Phosphate non-GAAP 128M Q2 2026 —
Adjusted EBITDA - Potash non-GAAP 278M Q2 2026 —
GAAP → non-GAAP reconciliation
GAAP Operating Earnings 195M
+76M Plus: Depreciation, Depletion and Amortization
+4M Plus: Accretion Expense
-95M Plus: Foreign Exchange Gain (Loss)
+1M Plus: Other Income (Expense)
+97M Plus: Notable Items
= Adjusted EBITDA - Potash 278M
Adjusted EBITDA – Corporate and Other non-GAAP -59M Q2 2026 —
Adjusted EBITDA – Mosaic Fertilizantes non-GAAP 60M Q2 2026 —
ARO cash spending $53M Q2 2026 —
Average Finished Product Selling Price $585 Q2 2026 —
Average finished product selling price (Phosphate) $754 Q2 2026 —
Blended Rock Cost Consumed in COGS non-GAAP $90 Q2 2026 —
Cash costs of U.S. mined rock/production tonne $62 Q2 2026 —
DAP selling price (fob plant) $773 Q2 2026 —
MOP Cash Cost of Production non-GAAP $84 Q2 2026 —
Phosphate Blended Rock Cost Consumed in COGS $105 Q2 2026 —
Phosphate cash conversion costs, production / tonne $129 Q2 2026 —
Production tonnes (Potash) 1.83M Q2 2026 —
Production volumes 1.8M Q2 2026 —
Realized cost Ammonia (per tonne) $621 Q2 2026 —
Realized cost Blended rock $90 Q2 2026 —
Realized cost Sulfur (per long ton) $522 Q2 2026 —
Sales of Performance Products 626K Q2 2026 —
Sales Volumes of produced product – million tonnes 0.7M Q2 2026 —
Total finished product tonnes sold 5.31M Q2 2026 —
Total tonnes produced (Phosphate) 1.43M Q2 2026 —
U.S. Rock Production tonnes 2.07M Q2 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Agricultural Inputs — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MOS
Mosaic Co
this stock
$6.08B -17.6% +8.4% — 11.7%
NTR
Nutrien Ltd.
$30.56B +6.0% — — 1.8%
CF
CF Industries Holdings, Inc.
$16.93B +49.7% +19.3% 8.2 6.1%
YARIY
Yara International ASA
$9.92B -4.5% — — 0.0%
CTVA
Corteva, Inc.
$5.42B -87.9% +2.9% 7.1 7.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
695
% held
99.5%
Net QoQ
+14.5M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
621
View
Short & Settlement
Short Interest Rising
Shares short
37.3M
Days to cover
3.4d
Change
+3.6M sh
View
Short Volume
Short vol %
44%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
4.4K
Value
$79.6K
As of
Oct 30, 2026
View
Off-Exchange
Off-exchange %
40.8%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Gilbert Cisneros
Amount
$1.0K–$15.0K
Traded
Apr 14, 2026
View
Financials
Financials
Revenue (FY)
$12.1B
Net income (FY)
$540.7M
EPS diluted
$1.70
View
Buybacks
Authorized
$3.0B
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 4, 2026
This year
21

Mosaic reported a $72.1 million net loss for the three months ended September 30, 2026 and a $602.5 million loss for the nine months ended September 30, 2026, as sulfur constraints and higher input costs pressured margins and phosphate production was curtailed.

View
Proposed Sales
Value
$508.6K
Shares
23.0K
Filed
Aug 19, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 4, 2026
View
Investor Relations
Latest news
The Mosaic Company Reports Third…
Published
Nov 3, 2026
View

Performance

5D 20D 120D MTD YTD
MOS -8.8% +14.9% -14.9% +7.9% -17.6%
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY -3.3% +21.2% -9.3% +13.2% -22.6%

Capital returns

Latest dividend
$0.22 / share · ex Sep 10, 2026
Declared · upcoming
$0.22 / share · ex Dec 4, 2026
Raised 4.8%
Paid (TTM)
$0.88 / share · 4 payouts
Dividend yield (TTM, derived)
4.43%
Full dividend history
Buyback program · as of Dec 31, 2025
Authorized
$3.00B
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1285785 CUSIP 61945C103 13F (30d) 668 filings 614 filers Visit website Investor relations